Press Releases

News Brief

Samsung Biologics to present at the 42nd Annual J.P. Morgan Healthcare Conference

Samsung Biologics to present at the 42nd Annual J.P. Morgan Healthcare Conference

Samsung Biologics will be participating in the 2024 J.P. Morgan Healthcare Conference in San Francisco between January 8-11. The conference is the largest and most informative healthcare investment symposium in the industry, connecting leading innovators and companies who are addressing global health and wellness challenges. 

 

This will be Samsung Biologics’ eighth year to present at the event’s main track session. John Rim, CEO and President of Samsung Biologics, is scheduled to share the company’s achievements in 2023 and business strategies for the new year on Tuesday, January 9th.

 

During the event, Samsung Biologics will also meet with investors and potential clients as the company continues to add fresh capacity and diversify its portfolio.

 

To arrange a meeting with the Samsung Biologics team, visit here.

 Samsung Biologics to present at the 42nd Annual J.P. Morgan Healthcare Conference


Samsung Biologics will be participating in the 2024 J.P. Morgan Healthcare Conference in San Francisco between January 8-11. The conference is the largest and most informative healthcare investment symposium in the industry, connecting leading innovators and companies who are addressing global health and wellness challenges. 

 

This will be Samsung Biologics’ eighth year to present at the event’s main track session. John Rim, CEO and President of Samsung Biologics, is scheduled to share the company’s achievements in 2023 and business strategies for the new year on Tuesday, January 9th.

 

During the event, Samsung Biologics will also meet with investors and potential clients as the company continues to add fresh capacity and diversify its portfolio.

 

To arrange a meeting with the Samsung Biologics team, visit here.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION